Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Delos Capital

Investor type Private Equity Firm


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 15
Average round size
The average size of a deal this fund participated in
Portfolio companies 11
Rounds per year 1.67
Lead investments 1
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 1
Key employees Soon
Stages of investment
Late Stage Venture
Private Equity

Areas of investment

  • Health Care
  • Biotechnology
  • Therapeutics
  • Medical Device
  • Pharmaceutical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Delos Capital:
Typical Co-investors
Delos Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Delos Capital:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Bain Capital Private Equity England, London, United Kingdom
Brandshoots Ventures India, Kolkata, West Bengal
Capital One Growth Ventures California, San Francisco, United States
DiGAME Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates
Fidelity National Title Insurance California, Santa Rosa, United States
Gfund Beijing, Beijing, China
Global Investment House Al Kuwayt, Kuwait, Safat
ICT Group N.V. Barendrecht, The Netherlands, Zuid-Holland
Innovus South Africa, Stellenbosch, Western Cape
Jollibee Food Pasig, Philippines, Rizal
MetLife Digital Accelerator powered by Techstars Cary, North Carolina, United States
NetSol Technologies Calabasas, California, United States
Parrot France, Ile-de-France, Paris
Shanghai Momoying Investment Development Center (LP) -
Solent Local Enterprise Partnership Hampshire, Portsmouth, United Kingdom
Southern Oregon Angel Investors Network Medford, Oregon, United States
The Vinik Family Foundation -
Zhiying Capital China, Shanghai
Zuma Ventures California, Santa Monica, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

OncoMyx Therapeutics

Health Diagnostics
$50M09 Dec 2021 Phoenix, Arizona, United States

OncoMyx Therapeutics

Health Care
$50M08 Dec 2021 Tempe, Arizona, United States

Imperative Care

Health Care
Medical Device
$260M15 Jul 2021 California, United States

$40M07 May 2021 San Diego, California, United States

Clover Biopharmaceuticals

Clinical Trials
Health Care
$230M22 Feb 2021 Sichuan


Health Care
Health Diagnostics
Medical Device
$15M14 Sep 2020 Bedford, Massachusetts, United States

Imperative Care

Health Care
Medical Device
$86M10 Dec 2019 California, United States

Clover Biopharmaceuticals

Clinical Trials
Health Care
$47M27 Nov 2019 Qingyang District, Sichuan, China

Health Care
$25M06 Jun 2019 Tempe, Arizona, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Delos Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: